EMEA-003061-PIP01-21
Key facts
| Active substance |
Otenaproxesul
|
| Therapeutic area |
Pain
|
| Decision number |
P/0472/2021
|
| PIP number |
EMEA-003061-PIP01-21
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylarthritis and juvenile idiopathic arthritis)
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Antibe Therapeutics Inc.
Email: info@antibethera.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|